COVID19 News
-
Singapore grants interim authorisation for first bivalent COVID-19 booster vaccine
COVID19 | News | 0 Comment | 14 Sep, 2022
Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...Read more
-
Australia to focus research on five virus families likely to cause future pandemics
COVID19 | News | 0 Comment | 30 Aug, 2022
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency,...Read more
-
Pfizer emerges as leading company in Asia for COVID-19 response
COVID19 | News | 0 Comment | 27 Aug, 2022
Pfizer has been ranked first in its COVID-19 response, patient centricity, patient safety and bringing innovative, high-...Read more
-
Singapore extends use of Moderna's COVID-19 vaccine for kids
COVID19 | News | 0 Comment | 24 Aug, 2022
The Health Sciences Authority (HSA) in Singapore has extended the authorisation of Moderna’s Spikevax COVI...Read more
-
Long COVID-19 study in Australia identifies potential diagnostic and therapeutic targets
COVID19 | News | 0 Comment | 23 Aug, 2022
Australia-based Antisense Therapeutics has announced the outcomes from its collaboration to study the neurological aspec...Read more
-
Mitigate COVID-19 impact on the Construction Industry
COVID19 | News | 0 Comment | 22 Aug, 2022
The city-state Singapore is currently facing another wave of COVID-19 infections driven by the Omicron variants, BA.5 an...Read more
-
USFDA grants EUA to Novavax COVID-19 vaccine for adolescents
COVID19 | News | 0 Comment | 22 Aug, 2022
Novavax has announced that its COVID-19 caccine, Adjuvanted (NVX-CoV2373) has received expanded emergency use autho...Read more
-
Nuvaxovid gets expanded provisional approval in NZ as COVID-19 booster for adults
COVID19 | News | 0 Comment | 18 Aug, 2022
US-based Novavax has announced that New Zealand (NZ)'s Medsafe has granted expanded provisional approval for Nuvaxovid (...Read more
-
Frontier Biotechnologies proposes treatments for acute and prolonged COVID
COVID19 | News | 0 Comment | 15 Aug, 2022
China-headquartered global biopharmaceutical company Frontier Biotechnologies announced positive results from the Phase ...Read more
-
South Korea approves Nuvaxovid COVID-19 vaccine for use in adolescents
COVID19 | News | 0 Comment | 14 Aug, 2022
US-based Novavax, Inc. has announced that partner, SK bioscience, has received a Post Approval Change Application approv...Read more
-
ADB approves $10 M for COVID-19 vaccines in Bhutan
COVID19 | News | 0 Comment | 02 Aug, 2022
The Asian Development Bank (ADB) has approved a $10 million loan to help the Government of Bhutan purchase safe and effe...Read more
-
Singapore grants interim authorisation for AstraZeneca’s antiviral mAb Evusheld
COVID19 | News | 0 Comment | 05 Aug, 2022
The Health Sciences Authority (HSA) in Singapore, in consultation with its Medicines Advisory Committee, has, gran...Read more
-
SK bioscience seeks European approval for COVID-19 vaccine
COVID19 | News | 0 Comment | 03 Aug, 2022
South Korea-based SK bioscience, a global innovative vaccine and biotech company dedicated to promoting human health fro...Read more
-
Japan approves Novavax's COVID-19 vaccine for adolescents
COVID19 | News | 0 Comment | 28 Jul, 2022
US-based Novavax has announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine received expanded manufacturing and marketi...Read more
-
NTU Singapore wins S$2.8 M grant for antiviral drug research
COVID19 | News | 0 Comment | 26 Jul, 2022
A team of scientists led by Lee Kong Chian School of Medicine (LKCMedicine) at Nanyang Technological University, Singapo...Read more
-
SK bioscience to manufacture Novavax' COVID-19 vaccine against omicron
COVID19 | News | 0 Comment | 22 Jul, 2022
South Korea's SK bioscience has extended its partnership with Novavax, a US-based biotechnology company specializing in ...Read more
-
Australia provisionally approves Moderna's COVID-19 vaccine for kids below 6 yrs
COVID19 | News | 0 Comment | 19 Jul, 2022
US-based Moderna has announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional regi...Read more
-
Brii Bio advances commercialisation of COVID-19 neutralizing antibody therapy in China
COVID19 | News | 0 Comment | 19 Jul, 2022
Brii Biosciences has announced that TSB Therapeutics (Beijing), a joint venture majority-owned by the company, is ...Read more
